Precision Biosciences Inc (DTIL)

Finanzdaten der Precision Biosciences Inc-Aktie (DTIL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00%-	10.84	34.20	0.01	0.02
	3.78%19.16	19.91	21.70	20.68	21.90
Research and Development	5.46%12.39	13.11	14.46	13.35	12.77
Depreciation and Amortization	15.38%0.25	0.30	0.35	0.35	0.38
Operating Income/Loss	111.14%-19.16	-9.08	12.51	-20.67	-21.88
Income/Loss From Equity Method Investments	-	-	-5.37	-0.59	-0.67
	77.06%-32.65	-18.44	20.13	-21.77	-23.52
Attributable To Parent	77.06%-32.65	-18.44	20.13	-21.77	-23.52
Basic Average Shares	4.96%25.86	24.63	-	11.82	11.05
Diluted Average Shares	4.96%25.86	24.63	-	11.82	11.05
Basic Earnings Per Share	68.00%-1.26	-0.75	-	-1.84	-2.13
Diluted Earnings Per Share	68.00%-1.26	-0.75	-	-1.84	-2.13